XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jul. 04, 2021
Jun. 28, 2020
Cash flows from operating activities:    
Net income $ 147,446 $ 19,335
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 22,739 22,808
Depreciation of property, plant, and equipment 8,510 11,162
Loss on disposal of property, plant, and equipment 4 1,214
Amortization of intangible assets 1,853 2,582
Intangible asset impairment charges 0 19,571
Excess and obsolete inventory charges 1,816 8,783
Operating lease asset impairment charges 0 2,534
Amortization of discounts or premiums on investments 1,840 328
Realized gain on sale of investments (68) (2,805)
Credit loss on investments 0 75
Revaluation of contingent consideration 0 (114)
Change in deferred income taxes 973 1,395
Accounts receivable (23,488) (8,957)
Unbilled revenue 3,844 3,804
Inventories (9,521) (1,664)
Prepaid expenses and other current assets (28,830) (25,461)
Accounts payable 16,058 143
Accrued expenses 206 15,806
Accrued income taxes (5,588) (25,411)
Deferred revenue and customer deposits 55,220 32,586
Other 1,711 (1,534)
Net cash provided by operating activities 194,725 76,180
Cash flows from investing activities:    
Purchases of investments (511,625) (317,540)
Maturities and sales of investments 270,696 387,765
Purchases of property, plant, and equipment (6,550) (6,985)
Net cash provided by (used in) investing activities (247,479) 63,240
Cash flows from financing activities:    
Net proceeds from issuance of common stock under stock plans 44,407 48,235
Repurchase of common stock (20,877) (51,036)
Payment of dividends (21,192) (18,972)
Payment of contingent consideration 0 (1,039)
Net cash provided by (used in) financing activities 2,338 (22,812)
Effect of foreign exchange rate changes on cash and cash equivalents (1,620) (2,018)
Net change in cash and cash equivalents (52,036) 114,590
Cash and cash equivalents at beginning of period 269,073 171,431
Cash and cash equivalents at end of period $ 217,037 $ 286,021